"The U.S. Food and Drug Administration approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry eye disease, on Monday, July 11, 2016. Xiidra is the first medication in a new class of drugs, called lymphocyt"...
DOSAGE AND ADMINISTRATION
The recommended dose of ACULAR LS™ (ketorolac tromethamine ophthalmic solution) ophthalmic solution is one drop four times a day in the operated eye as needed for pain and burning/stinging for up to 4 days following corneal refractive surgery.
Ketorolac tromethamine ophthalmic solution has been safely administered in conjunction with other ophthalmic medications such as antibiotics, beta blockers, carbonic anhydrase inhibitors, cycloplegics, and mydriatics.
ACULAR LS™ (ketorolac tromethamine ophthalmic solution) 0.4% is supplied sterile in an opaque white LDPE plastic bottle with a white dropper with a gray high impact polystyrene (HIPS) cap as follows:
5 mL in 10 mL bottle- NDC 0023-9277-05
Note: Store at 15°C - 25°C (59°F- 77°F).
This product is manufactured and distributed by ALLERGAN under license from its developer, Roche Palo Alto LLC, Palo Alto, California, U.S.A. May 2003. FDA Rev date: 12/1/2008This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 1/11/2017
Additional Acular LS Information
Acular LS - User Reviews
Acular LS User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.